OpenAI acquires Orchestra Bio to strengthen its life sciences efforts
OpenAI has acquired the startup Orchestra Bio. The company says it is bringing Orchestra's team and technology into its work on Rosalind, its AI model for life sciences research. Orchestra's technology will also be applied to Rosalind Workbench, a tool designed to help researchers plan experiments and analyze results. The move expands OpenAI's biotech business.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.



Discussion (0)
Log in to join the discussion and vote.
Log in